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Abstract
Drug abuse, currently a national epidemic affecting millions of Americans, causes numerous health issues including increased dental disease. There are several factors which can contribute to an increase in caries and missing teeth. One of the most discussed
mechanisms is xerostomia. Drug abusers tend to have large sugar intakes which exacerbates the problems caused by xerostomia.
Drug abusers are also at risk for oral infections associated with dental decay due to their altered saliva composition. Unfortunately,
once the symptoms are present there is little that can be done to correct them and the goal of the treating dentist should be
increased dental hygiene and ongoing prevention.
Introduction
Substance abuse and misuse is a national public health crisis.
In 2015, more than 27 million people in the United States reported current illicit drug use or misuse of prescription drugs.
In addition, The National Survey on Drug Use and Health reported that over 66 million people misuse alcohol in a month.
Alcohol and drug misuse and related disorders are taking an
enormous toll on individuals, families, and society as a whole
as a result of the increased costs of healthcare associated with
these conditions.

Methods
The articles mentioned in this paper were collected and compiled using research available to the public through Google
Scholar, PubMed, and EBSCO host. Some of the articles may
be under restricted access to academic circles and was made
available to the author through the TouroLib system. Sources
were evaluated for usefulness based on publication date and
original publication source.

Commonly abused drugs
In addition to the many psychological and medical challenges
presented by drug abuse, there are also extensive oral health
problems which drug abuse causes. To further understand the
nature of the oral health issues, it is first necessary to understand what is considered a drug and the major classes of drugs
which people tend to abuse. Drugs can be defined as an exogenous chemical not necessary for normal cellular functioning that
significantly alters the function of certain cells in the body, even
when taken in relatively low doses. Endogenous neurotransmitters are not drugs, synthetic chemicals which mimic the effects
of these endogenous chemicals, however, are considered a drug.
Another stated qualification for a drug is that it is effective even
in small quantities, this is an important part of the definition, as
large quantities of any substance will alter the normal function of
cells (Carlson, 2013).
People abuse drugs for the euphoric feelings and their ability to
cause “mental detachment”.The reason why people do not abuse
antibiotics is because they do not induce these feelings.The drugs
which people abuse can be separated into two distinct categories,
central depressants and stimulants, defined by their effects on
neurotransmitters. In the world of illicit drugs, these substances
are often referred to by a “street name”. It is important for a
clinician to be familiar with not only the pharmaceutical name

of a drug but with the street name as well, since many patients
may not know the pharmaceutical name and may resort to using
street names (Rome, 2001).
Stimulants, or “Uppers”, is a class of drugs that mimic the effects of the sympathetic nervous system. The endogenous agonists of the sympathetic nervous system are the catecholamines;
epinephrine, norepinephrine, and dopamine. The catecholamines
function as both hormones and neurotransmitters. The pharmacokinetics of these drugs can affect a multitude of mechanisms,
direct activation of postsynaptic receptors, the breakdown and
reuptake of neurotransmitters, and stimulating production of
catecholamines. Stimulants include, caffeine, ephedrine, nicotine,
and cocaine.
One of the most commonly abused stimulants is methamphetamine. Methamphetamine, also known as, meth, speed,
crank, tweek, chalk, amongst other names, is a white crystalline
powder. Methamphetamine can be snorted, smoked, or injected.
The popularity of methamphetamine is in large part because of
its ease to obtain. Methamphetamine can be synthesized at home
from commonly available ingredients (Lineberry and Bostwick,
2006). The FDA approves methamphetamine hydrochloride,
sold under the name Desoxyn, to treat attention deficit disorder with hyperactivity as well as exogenous obesity, however
the FDA advises that the inherent risk of methamphetamine
must be strongly considered when prescribing it. The physical
effects of methamphetamine are systemic. They include, loss of
appetite, hyperactivity, tachycardia, bradycardia, rapid breathing,
dry mouth, excessive sweating, and bruxism. Methamphetamine
is taken recreationally to produce euphoria as well as an aphrodisiac. This article will discuss the effects of methamphetamine
on oral health. Methamphetamine causes periodontal disease as
well as rampant caries (cavities), the effect of methamphetamine
on oral health is so unique that it has been referred to as Meth
Mouth (Rommel, et. al, 2015).
The second class of drugs is depressants, or, “downers”.
Depressants, are the opposite of stimulants, they lower neurotransmission levels and depress arousal and stimulation in
the brain. The pharmacokinetics of depressants are slightly
more complicated. Neurons communicate through excitatory
synapses, one neuron excites another which excites another
neuron, and so on. If this excitatory process would happen uncontrollably, the neurons in the brain would be firing constantly,
resulting in a seizure. To prevent this from happening, there is a
class of neurons which have inhibitory effects. These neurons
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secrete GABA (gamma-aminobutyric acid) which has a postsynaptic inhibitory effect. Depressants activate the various GABA
receptors which results in an overall inhibitory effect. The most
commonly prescribed class of depressants are benzodiazepines.
Benzodiazepines are drugs which are used to reduce anxiety,
promote sleep, and reduce seizures. Valium (diazepam) and
Librium (chlordiazepoxide) are two common benzodiazepines.
Other common depressants include barbiturates, cannabis, and
alcohol (Carlson, 2013).
Opioids, the current medical terminology which refers to
both endogenous and exogenous opioid, are drug which have
the properties of both a depressant and a stimulant. Opioids
create a state of euphoria, much like a stimulant, but its physical
expression is similar to that of a depressant, i.e. slowed breathing, sedation, and hypothermia (NAABT.org). What is particularly scary about opioids is their tendency to cause respiratory
depression. Even a small dose can be lethal, when taken together
with Xanax (alprazolam), or other commonly prescribed drugs,
which also causes respiratory depression.
With the exception of alcohol, drug abuse was limited to
a small population who tended to be socially disadvantaged.
Today, drug abuse is evenly distributed across all social strata
(Friedlander and Mills, 1985). The stereotypical drug abuser is
one of low socioeconomic status, and frequently neglects both
general and oral hygiene. With the increase of abusers who do
not fit this image, the issue of drug abuse, and its effect on oral
health, has now come to the forefront.

Drug Abuse and Dental Decay
The correlation between drug abuse and severe dental decay has
long been known. A study conducted in Iran was composed of
5,900 people; 2,662 were men (45.1%), between the ages of 15
and 75. One thousand and eleven (17.1%) of those people used
opioids. The participants in the study underwent a face to face
interview with a trained practitioner, during which information
pertaining to the frequency of their drug use was obtained. In
accordance with the Diagnostic and Statistical Manual of Mental
Disorders (DMS-IV2), individuals who reported taking opioids at
least three times a week were considered addicted. After the interview a dentist performed a thorough oral exam. Dental decay
was recorded according to the DMFT index (decayed, missing,
and filled teeth) established by the World Health Organization.
Dental plaque and gum disease were also noted using the plaque
index and the community periodontal index (CPI).
For people addicted to opioids, participants had a mean number of 9.07 teeth missing, compared to a mean of 6.42 for non-addicted users.There was a mean of 9.50 decayed teeth for addicted
opioid users compared to 8.95 decayed teeth for participants not
addicted to opioid use. Similar results for the number of filled
teeth as well; 6.36 fillings for addicted participants compared to
a mean of 3.89 for non-addicted participants. Overall the DMFT

6

index for addicted users had a score of 17.10 compared to 13.10
for non-addicted users (Mohammadi, et al. 2017).
The authors say that the data proves a clear increase in the
number of missing, decayed, and filled teeth, in opioid users.
There are however some shortcomings with the study.Although
other studies consider self-reporting of drug use a reliable indicator of actual drug use, there are of course people who are not
totally honest with their drug use habits. More challenging, however, is the difference in age among the participants in the trial.
The mean age of the addicted individuals was 56.01 while the
mean age of non-addicted individuals was 48.19. This difference
is statistically significant (p=0.00) considering the large sample
size. Some of the discrepancy in the DMFT index between the
addicted and non-addicted individuals can be associated with
the age difference as aging is an influence in tooth loss. The
study would have been more reliable had the mean age of the
two groups been the same or at least statistically insignificant.
A study of 571 methamphetamine users in Los Angeles
County, California was conducted and also shows a correlation
between methamphetamine use and dental decay. This study
focused exclusively on methamphetamine users and compared
their results to a study done by National Health and Nutrition
Examination Survey (NHANES). NHANES does a survey every
two years, with participants selected to be nationally representative without being selected based on risk factors or pre-existing conditions. This study was conducted to answer two questions, do methamphetamine users have a higher rate of dental
disease compared to non-users, and are different teeth affected
between methamphetamine users and non-users.
Participants in the study were selected based on stratified
sampling protocol of heavy, mild, and moderate, methamphetamine users. Intraoral exams were conducted by dentists who
were trained by the national examiner in the NHANES study. All
protocols of the study adhered to NHANES regulations so that
the two studies can have maximum comparability. Although many
variables were tested, the main one focused on was the DMFT
index. As opposed to the Iran study which relied on self-reporting of drug use alone, this study utilized urine testing to confirm
drug use. Data was also collected on sociodemographic and
behavioral variables; gender, age, ethnicity, education, history of
smoking, frequency of basic oral hygiene, and soda consumption.
Whereas the Iran study compared opioid users and non-users with little regard for sociodemographic information and the
differences it may make, this study divided the participants into
five propensity score groups, with each group having comparable sociodemographic backgrounds as the participants in the
NHANES study. Multiple statistical analysis tests; t tests, chisquare tests, and Fisher tests, were used to confirm the accuracy in comparing the data from the Los Angeles County study to
that of the NHANES study.
Of the 571 participants in the study, 19 of them were
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completely edentulous (missing teeth). A shocking number considering that mean age of the participants was only 44. Compared
to the NHANES study, methamphetamine users were forty percent less likely to have all their teeth. Methamphetamine users
were also found to have approximately four times more caries
and were twice as likely for the caries to be untreated. Close
to twenty percent more methamphetamine users had decayed,
missing, or filled teeth compared to the NHANES participants.
Methamphetamine users were also more likely to have missing
teeth when compared to the demographically similar NHANES
participants (Shetty, et.al. 2016).
Similar studies from other locales also point to an increase
in both the number of missing teeth and the number of carries
in patients addicted to drugs. A study in Queensland, Australia
studied several drugs and their role in dental decay (Reece,
2007). Another study, based in Munich, Germany also determined that there is a correlation between methamphetamine
and rampant caries (Rommel, 2015).

Xerostomia
The most common complaint methamphetamine users express
is that of “dry mouth” (Shafer, 2005). One study has 72% of
substance abusers reporting suffering from an excessively dry
mouth (Rommel, et. al., 2016). Dry mouth or xerostomia, is a
fairly common complaint with estimates ranging between 0.9%
and 64.8% of the population suffering from a form of dry mouth.
There is a lack of data on the prevalence of xerostomia leading
to such a wide range (Navazesh and Kumar, 2009). Xerostomia
is usually associated with salivary gland hypofunction.
Although saliva is ninety-eight percent water, the other two
percent contains many important substances. Included in those
substances are the electrolytes, sodium, potassium, calcium,
chloride, bicarbonate, and phosphate. Saliva also contains important enzymes needed for digestion, amylase, lingual lipase,
and kallikrein. Another important component of saliva is its antimicrobial enzymes; lysozyme, lactoperoxidase, lactoferrin, and
immunoglobulin A.
The importance of the electrolytes in saliva is their ability to
regulate and maintain the pH of the mouth. Ideally, the pH of
the mouth should be between 6.2 and 7.4. Anymore acidic and
the acid can dissolve the hard minerals which make up the teeth.
The ions present in saliva act as a buffer, keeping the pH within
that important range.
Although there have been some studies which did not find
a correlation between decreased saliva production and drug
abuse (Busfield, 1961), more recently there are others that have
reported a correlation (Heng, et al. 2008). The mean saliva production of a person is 1-2 ml/min. A stimulated salivation of less
than 0.7 ml/min is considered low. In one study, the average
methamphetamine user had an average saliva flow rate of only
0.36 ml/min (Rommel, et. al., 2016).

Saliva production is regulated by both the sympathetic and
parasympathetic nervous systems. When norepinephrine
binds to the alpha-adrenergic receptor it causes an increase
in calcium levels which results in increased saliva production.
Methamphetamine seems to activate the alpha-2-receptor
which is a salivary inhibitor in the brain (Saini, 2005).
Xerostomia is considered to be an adverse drug event of
properly prescribed opioid medication (Chapman, et. al., 2010).
Although a concrete mechanism between opioid use and xerostomia has not been found, there are several working theories
as to what may cause these symptoms. One theory is based
upon the proven correlation between opioid use and decreased
pancreas function. Perhaps there is a similar effect on the salivary glands which also are exocrine glands. Another theory is
that after opioid use, there is a clear change in color, from red
to very pale, of the oral mucosa. This change in color suggests
local vasoconstriction of the capillaries and small arterioles in
the mouth.This decreased blood flow can also inhibit saliva production (Odeh, et al. 1992).
Additionally, drug abusers also tend to go long periods with
inadequate food and drink. This leads to a generalized dehydration, resulting in decreased saliva production especially
when coupled with the hypermetabolic effects of illicit drugs
(Goodchild, et al. 2007) Another theory points to the concomitant use of antidepressants and other drugs which can also
cause xerostomia (Darke and Ross, 2000).

Sugar Intake
Regardless of any proven cause of drug abuse induced xerostomia, the mere fact that drug abusers consider their mouth to
be dry, leads to another problem. Drug abusers tend to crave
sugar and drink large amounts of non-diet soda. Mountain Dew
is a commonly reported favorite drink of methamphetamine
users and contains 31 grams of sugar, the equivalent of eight
sugar cubes, in a single eight ounce serving. When considering that that is a single serving, and one can have many cups
over the course of one day, that is an abnormally high level of
sugar consumption (Goodchild, et al. 2007). One case report
mentions a light user of methamphetamine, who would drink
1.5 liters of soda a day, that is a staggering one hundred and
ninety six grams of sugar consumed from drinks alone (Wang,
et al. 2012). As part of the Los Angeles County survey of 541
methamphetamine users, researchers obtained the number of
non-diet soda drinks they had per day. The results of the study
when compared to national averages, show a direct correlation
between non-diet soda consumption and methamphetamine
use. Although for years there was anecdotal evidence to this,
this was the first survey to confirm it from a scientific and statistical standpoint (Murphy, 2016).
Opioid users have an additional factor which increases their
sugar levels. There are three main opioid receptors in the brain;
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mu, kappa, and delta (Titsas and Ferguson 2002). Preclinical animal studies suggest that action of mu and kappa agonists at
the nucleus accumbens shell, hypothalamus, and paraventricular
nucleus is associated with a development of a preference for
sweetened food. Furthermore, eating sugar results in a down
regulation of enkephalin MRNA production which then results
in an increase in mu receptor agonism (Mysels and Sullivan,
2010). This increase in sugar consumption, especially when
coupled with hyposalivation, leads to rampant caries and subsequent tooth loss.
Methamphetamine abuse leads to hyperactivity and excessive
neuromuscular activity which causes bruxism (Rommel, et. al.,
2016). Bruxism is excessive jaw clenching and teeth grinding.
Opioid users also suffer from bruxism as there is an increase in
neurosis which results in jaw clenching and teeth grinding (Titsas
and Ferguson, 2002). Although bruxism is relatively common in
non-drug dependent adults as well, the degree of grinding and
clenching seems to be much greater in the addicted population.
Bruxism shows to be particularly damaging to drug abusers due
to the already weakened enamel from sugar consumption, poor
oral hygiene, and hyposalivation.

Oral Infections
Another problem which drug abusers face is oral candidiasis.
Opioids have been found to have an inhibitory effect on the
phagocytosis of Candida by macrophages (Titsas and Ferguson,
2002). Saliva also plays a role in preventing oral candidiasis as it
unifies the innate immune defense against Candida Albicans and
prevents its proliferation. Saliva also contains the immunoglobulin IgA which aggregates the Candida Albicans cells and then destroys them by swallowing the aggregate (Salvatori, et al. 2016).
Candida Albicans has also been found to cause pulpal inflammation, resulting in tooth loss, when the microorganism reaches
the pulp through dental caries (Baumgartner et. al. 2000).
It has been known for a long time that Streptococcus mutans
is a pathogenic organism which causes enamel loss and caries
(Loesche, 1986). Recent clinical studies have shown large numbers of Candida albicans along with Streptococcus mutans in
plaque obtained from carious lesions. Scientists were surprised
to find this as no other co-colonization between this bacteria and yeast were previously known (Carvalho et al. 2006).
Recent research shows that co-culture of Candida albicans and
Streptococcus mutans with sucrose resulted in production of
the S. mutans exoenzyme (GtfB) that bound to mannans and
β-1,3 glucans found on the fungal outer cell wall, allowing them
to survive the innate immune factors present in the mouth. In
the same study, it was shown that coinfection in rats with both
C. albicans and S. mutans increased the severity and number of
smooth-surface caries lesions by 2-fold in the presence of sucrose (Falsetta et al. 2014). It is no surprise then that drug abusers who have an increased presence of both Candida albicans
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and Streptococcus mutans as well as a large sugar intake are at
risk for severe caries.
One theory for the increase of dental disease in drug abusers
was the caustic nature of inhaled and smoked drugs (McGrath
and Chan, 2005). The Los Angeles County study, however, found
that the dental consequences of methamphetamine abuse were
more pronounced in users who injected the drug (Shetty, 2016).
With injection of the drug there should be little or no decay
if the issue was the caustic nature of the smoke. Heavy drug
abusers tend to inject the drug as it provides for a quicker and
stronger “high.” The poor health of heavy drug abusers and the
increase of the associated side effects are probably responsible
for the findings of the Los Angeles County study.

Treatment Concerns
Drug abusers will usually only visit the dentist after they stop
abusing the drug and they are suffering from severe pain. It is
therefore important that dentists be aware of previous drug
abuse to avoid prescribing a medication which may cause relapse.
Most users will not admit that they are or were users for fear of
being judged.Therefore dentists must be trained to recognize the
main signs and symptoms of drug abuse (De-Carolis, et al., 2015).
Dentists should also take notice of skin lesions which can indicate
intravenous drug use. The practitioner may decide to take the
patient’s blood pressure as a way of disguising their search for
needle tracks (Saini, et al. 2013). Dentists should not make use
of pre-written prescription forms as it can potentially be used to
obtain drugs which were not prescribed (Smit and Naidoo, 2015).
When treating patients who have a history of drug abuse, providing adequate pain relief can be challenging. Most abusers have
a tolerance to several pain medications as a result of drug abuse,
and other medications may cause relapse (Saini, 2013). Local anesthetic containing epinephrine (commonly used as a vasoconstrictor in dental surgery) must be avoided as there are known
drug interactions between epinephrine and commonly abused
drugs. The importance of this must be stressed to the patient
as it may result in cardiac dysrhythmias, cerebrovascular injury,
and even myocardial infarctions (Smit and Naidoo, 2015). Dentists
may recommend non-steroidal analgesics, for example, ibuprofen
and naproxen. Acetaminophen can be used as well (Saini, et al.
2013).

Conclusion
Drug abuse is considered an epidemic and there is a large effort
underway to inform the public of the dangers involved. Drug
abuse has serious detrimental effects on the body. Oral health
is one of the most noticeable side effects, as drug abusers are
commonly missing multiple teeth. Dentists must know how to
recognize the signs of drug abuse and can be on the forefront
of fighting this epidemic.
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